Your Article Summary
See Latest ArticlesUK Service Providers Look to the New World
BioPharm, 06/22/09
The decline of financial support for the biopharmaceutical industry has been a huge blow to the contract research and manufacturing industries. According to the National Venture Capital Association, venture capital funding for the biopharmaceutical industry in the US dropped 46% in the first quarter of 2009, to just $577 million; it had averaged over $1 billion per quarter throughout this decade.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
GlaxoSmithKline, 12/18/09
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09
CCHIT Appoints Officers
HealthDataManagement, 12/18/09